Completed

NCT Number: NCT02903706

Prevalence of Malaria Parasites in People Working in Illegal Gold Mining in French Guiana

Malaria is the most widespread parasitic illness in the world, and it is endemic to Guiana. Although the number of cases has decreased since 2005, sources of infection still remain, particularly within illegal gold mines. These malaria carriers/sufferers often use self-medication to deal with malaria symptoms, resulting in a risk of resistance to anti-malarial treatments, and particularly to artemisinine. The mobility of this population across the Guiana Shield increases both the risk of malaria spreading and the resistance of this illness to treatment in the region, and puts the population at risk of new outbreaks of this disease despite the great efforts put into anti-malarial policy in this region.

Fighting malaria within this population is therefore a dual public health challenge: on the one hand, make it possible for the WHO to eliminate malaria from the Guiana Shield by 2017, on the other to limit resistance to artemisinine in this region. However, Guiana's particular context - namely the illegal status of gold mines and the difficult geographical access, the Harpie military operations, the illegality of carrying out malarial diagnosis tests and treating cases without the presence of a health professional - prevents us from achieving this goal using the same tools as our neighbours in Suriname, whose " Looking for Gold, Finding Malaria " programme was a success.

A better understanding of the malarial epidemiology in this population will enable us to propose innovative, more adapted measures to combat malaria within these guyanese populations. This is an transversal, multicentric observational study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Malaria Epidemiology Infections Mosquito-Borne Diseases Parasitic Diseases Protozoan Infections Vector Borne Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

Main Aim:

To estimate the prevalence of Plasmodium carriers in the population of illegal gold mine workers in French Guiana.

Secondary aims:

Evaluate the proportion of different Plasmodium species affecting this population and

Determine parasitaemia levels;
Evaluate the gametocyte index;
Map the number and proportion of P. falciparum cases for the different river sites where gold mining is carried out;
Determine the lifestyle, knowledge, attitude and behaviour of these populations concerning malaria;
Estimate the prevalence of mutations linked to the resistance of parasites to artemisinine derivatives;
Analyse the global genetic diversity of these parasites.
Evaluate the global health of gold miners

The results of this study will make it possible to characterise the malaria epidemic in illegal gold-mining sites across French Guiana, evaluate the size of the human reservoir and the prevalence of ACT-tolerant parasites, identify the most urgent areas to be dealt with, suggest appropriate plans of action for this, and adopt more efficient public information campaigns.

Target Population: People working on illegal gold mining sites in French Guiana.

Inclusion criteria

works on a gold mining site in French Guiana
has been at the resting site for less than seven days
is over the age of 18
accepts to take part in this study

Exclusion criteria

refuses to take part in the study
is under the age of 18

The sampling of the 240 people needed for this study will be achieved through chance meetings and the resulting snowball effect at gold mining resting sites on the Surinamese banks of the Maroni river.

Study Protocol:

Acquisition of authorisations from the competent French authorities
Authorisation from the competent Surinamese authorities
Recruitment of one mediator/translator, one state registered nurse and one doctor
Collaboration with Dr Cairo (program "looking for gold, finding malaria) in Suriname to plan the field missions
Teams from Suriname and French Guiana will work joinly in the field: eligible persons will be enrolled in the study, the others can be tested by the Surinamese team.
Inclusion of subjects through chance meetings and the snowball effect at resting sites
Consent of patients and checking of inclusion criteria
Performance of three diagnostic tests for each person, including

an RDT on site
If the RDT is positive: complete treatment given to patient following national guidelines;
If necessary, provision of a results sheet describing the necessary doses for treatment;

Performance of thick and thin blood smears for transport to the CHAR parasitology laboratory for analysis;
Collection of a 5ml (EDTA) tube of blood d'un tube de sang de 5ml reserved in an icebox between 4°C et 10°C for the CNR malarial parasitology lab at the Institut Pasteur de la Guyane;
Completion of the questionnaire;
Temperature is taken;
Patient is provided with a brochure about malaria in Portugese and/or Sranantango;
Provision of an insecticide-treated net.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

works on a gold mining site in French Guiana
has been at the resting site for less than seven days
is over the age of 18
accepts to take part in this study

Exclusion criteria

refuses to take part in the study
is under the age of 18

Treatment and study plan

Measure of Plasmodium prevalence (PCR)

Other

Primary outcomes

prevalence of malaria positive individuals (symptomatic or not symptomatic)

Time frame: 1 month

every participant gives a capillary blood specimen which is then screened for malaria using PCR in order to obtain a prevalence of malaria positive individuals (symptomatic or not symptomatic)

Secondary outcomes

Microscopy: thick and thin smear

Time frame: 1 month

Each participant is screen for malaria using classic microscopy on thin and thick smears in order to obtain a prevalence of malaria positive individuals and to evaluate parasite quantities, and gametocyte carriage (transmission potential). If either thin or thick smears are positive then the patient is estimated to have smear positive malaria.

Sponsors and collaborators

Lead sponsor

Centre Hospitalier de Cayenne

Other

Registry information

Acronym: ORPAL

Important dates

Study start: 2014
Primary completion: 2015
Study completion: 2015
First posted: Sep 16, 2016
Registry last updated: Sep 16, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed